Institutional members access full text with Ovid®

Share this article on:

Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia

McCluggage, W. Glenn F.R.C.Path.; Colgan, Terry M.D.; Duggan, Maire M.D.; Hacker, Neville F. M.D.; Mulvany, Nick M.D.; Otis, Christopher M.D.; Wilkinson, Nafisa F.R.C.Path.; Zaino, Richard J. M.D.; Hirschowitz, Lynn F.R.C.Path.

International Journal of Gynecological Pathology: January 2013 - Volume 32 - Issue 1 - p 45–65
doi: 10.1097/PGP.0b013e31825d808b
Pathology of the Corpus: Review Article

The International Collaboration on Cancer Reporting is a quadripartite alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, and the Canadian Partnership Against Cancer. The International Collaboration on Cancer Reporting was formed with a view to reducing the global burden of cancer data set development and reduplication of the effort by different international institutions that commission, publish, and maintain standardized cancer-reporting data sets. The resultant standardization of cancer reporting would be expected to benefit not only those countries directly involved in the collaboration, but also others not in a position to develop their own data sets. The main objective of the International Collaboration on Cancer Reporting is to develop an evidence-based–reporting data set for each cancer site, and to this end, a project to develop data sets for prostate, endometrium, and lung cancers and malignant melanoma was piloted by the quadripartite group. This review describes the process of development of the endometrial cancer data set.

Department of Pathology (W.G.M.), Belfast Health and Social Care Trust, Belfast, Northern Ireland

Department of Pathology (N.W.), St James’s Hospital, Leeds

Department of Pathology (L.H.), Birmingham Women’s Hospital, Birmingham

Royal College of Pathologists (L.H.), Working Group on Cancer Services, UK

ICCR Endometrial Cancer Panel Lead (W.G.M.)

Gynaecological Pathology Section (T.C.), Mount Sinai Hospital, Toronto

Department of Pathology and Laboratory Medicine (M.D.), University of Calgary, Alberta, Canada

School of Women’s and Children’s Health (N.F.H.), University of New South Wales

Gynaecological Cancer Centre (N.F.H.), Royal Hospital for Women, Sydney

Department of Anatomical Pathology (N.M.), Austin Hospital, Heidelberg

Department of Gynaecological Oncology (N.M.), Mercy Hospital for Women, Melbourne, Australia

Tufts University School of Medicine (C.O.), Baystate Medical Center, Springfield, Massachusetts

Department of Pathology (R.J.Z.), Hershey Medical Center, Pennsylvania

The authors declare no conflict of interest.

Address correspondence and reprint requests to W. Glenn McCluggage, FRCPath, Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, UK. E-mail: glenn.mccluggage@belfasttrust.hscni.net.

©2013International Society of Gynecological Pathologists